Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

With two billion people overweight or obese and the obesity treatment market expected to reach $200 billion by 2031, Olio ...

Tirzepatide is available through both the type 2 diabetes medication Mounjaro and weight-loss medication Zepbound. A new study funded by Eli Lilly reports that people without diabetes can lose up ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

looked at nine patients who reported vision loss after taking semaglutide or tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro and Zepbound. Norris at his current weight of 230 ...

A code of secrecy surrounds the drug’s prevalence on campuses and in sororities.” ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. The launch ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...